<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Shikha Dixit</style></author><author><style face="normal" font="default" size="100%">Sugandha Tiwari</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Review on Plants for Management of Diabetes in India: An Ethno- Botanical and Pharmacological Perspective</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Diabetes management</style></keyword><keyword><style  face="normal" font="default" size="100%">Ethnopharmacology</style></keyword><keyword><style  face="normal" font="default" size="100%">Herbal drugs</style></keyword><keyword><style  face="normal" font="default" size="100%">India</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style  face="normal" font="default" size="100%">November 2020</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">12</style></volume><pages><style face="normal" font="default" size="100%">1801-1810</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;Diabetes mellitus is a prevalent chronic disease, which is recognized as a common threat to health in the last decade, especially in Asia. It is a lifestyle disease which may cause a number of complications in the body of humans like cardiac failure and dysfunctioning of urinary tract. &lt;strong&gt;Materials and Methods:&lt;/strong&gt; The data is obtained from various search tools and electronic databases like, scientific literature, Google scholar, Google, Pubmed, Web of science and Scopus. &lt;strong&gt;Results: &lt;/strong&gt;Major therapy for diabetes is insulin, oralantidiabetic drugs, and herbal treatment. However, insulin and oral anti-diabetic drugs come with a number of side effects and cannot be afforded by people with below poverty line. The herbal medicines have performed a satisfactory clinical practice for the management of diabetes mellitus. Moreover, pharmacological &amp;amp; phytochemical screening of medicinal plants has also witnessed the hypoglycaemic effects of these plants in treating diabetes mellitus. Majority of the modern drugs like metformin, atropine, digitalis, etc. are also originated from plants. &lt;strong&gt;Conclusion: &lt;/strong&gt;The current paper presents a review of medicinal plants used for diabetes management in India. The therapeutic potential, ethnobotanical use, and their pharmacological evaluations are highlighted for harnessing the anti-diabetic potential of these plants by the Indian healthcare system.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6s</style></issue><work-type><style face="normal" font="default" size="100%">Review Article</style></work-type><section><style face="normal" font="default" size="100%">1801</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Shikha Dixit*, Sugandha Tiwari &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;Department of Botany, DGPG College, CSJMU Kanpur, INDIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Olga Trifonova</style></author><author><style face="normal" font="default" size="100%">Olga Evdokimova</style></author><author><style face="normal" font="default" size="100%">Vera Prokofieva</style></author><author><style face="normal" font="default" size="100%">Alexey Matyushin</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Rationale for Manufacturing of Cut-Pressed Granules from Herbal Raw Material Rich in Essential Oil: An Example of Chamomile Flowers and Sweet Flag Rhizome</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Chamomile</style></keyword><keyword><style  face="normal" font="default" size="100%">Cut-pressed granules</style></keyword><keyword><style  face="normal" font="default" size="100%">Dosage form</style></keyword><keyword><style  face="normal" font="default" size="100%">Essential oil</style></keyword><keyword><style  face="normal" font="default" size="100%">Herbal drugs</style></keyword><keyword><style  face="normal" font="default" size="100%">Sweet flag</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style  face="normal" font="default" size="100%">October 2019</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">11</style></volume><pages><style face="normal" font="default" size="100%">1285-1289</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;Currently, there are at least 43 different dosage forms present on the Russian Federation pharmaceutical market. A novel, unique dosage form – cut-pressed granules (CPG) – was developed in order to improve manufacturing characteristics and, therefore, quality of herbal drug products released in tea bags. However, treatment conditions may result in decreased levels of active substances in some of the plants, especially those containing essential oil, which is prone to degradation. The aim of this study was to assess feasibility of CPG manufacturing from herbal raw material rich in essential oil. &lt;strong&gt;Materials and Methods: &lt;/strong&gt;Different morphological groups of raw material from two commonly used medicinal plants, chamomile (&lt;em&gt;Matricaria recutita&lt;/em&gt; L.) flowers and sweet flag (&lt;em&gt;Acorus calamus&lt;/em&gt; L.) rhizome, were chosen as the objects of the study. Qualitative composition of lipophilic constituents in herbal raw materials and CPG was assessed using thin-layer chromatography. Essential oil content was determined by steam distillation.&lt;strong&gt; Results:&lt;/strong&gt; The results confirmed equivalence of chromatographic profiles for the analyzed raw materials and CPG; thus, granulation didn’t affect qualitative composition of lipophilic components in chamomile flowers and sweet flag rhizome. The study also showed that the granulation process, in fact, promoted stability of the dosage form: during long-term storage the content of essential oil in all of the assessed cut-pressed granules was equivalent or higher than in corresponding herbal raw material. &lt;strong&gt;Conclusions:&lt;/strong&gt; It can be concluded that &lt;em&gt;Matricaria recutita &lt;/em&gt;L. flowers and &lt;em&gt;Acorus calamus&lt;/em&gt; L. rhizome can be used as herbal raw material for CPG manufacturing.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">1285</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Olga Trifonova&lt;sup&gt;1,2&lt;/sup&gt;, Olga Evdokimova&lt;sup&gt;3&lt;/sup&gt;, Vera Prokofieva&lt;sup&gt;4&lt;/sup&gt;, Alexey Matyushin&lt;sup&gt;5&lt;/sup&gt;,* &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Pharmacy, Sechenov First Moscow State Medical University, Moscow, RUSSIAN FEDERATION.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;JSC “Krasnogorskleksredstva”, Krasnogorsk, RUSSIAN FEDERATION.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Federal State Budgetary Institution Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation, Moscow, RUSSIAN FEDERATION.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;A.P. Arzamastsev Department of Pharmaceutical and Toxicological Chemistry, Sechenov First Moscow State Medical University, Moscow, RUSSIAN FEDERATION.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;5&lt;/sup&gt;Department of Analytical and Forensic Toxicology, Sechenov First Moscow State Medical University, Moscow, RUSSIAN FEDERATION.&lt;/p&gt;
</style></auth-address></record></records></xml>